Literature DB >> 1092331

The regulation of transcription in bacteriophage T5-infected Escherichia coli.

C Szabo, B Dharmgrongartama, R W Moyer.   

Abstract

The expression of bacteriophage T5-specific RNA and protein in infected cells is temporally separated into three classes: class I (preearly), class II (early), and class III (late). By immunoprecipitation techniques we have shown that T5 infection of cells leads to the synthesis of one class I polypeptide (11,000 daltons) and two class II polypeptides (90,000 and 15,000 daltons) capable of binding to the RNA polymerase of the host Escherichia coli cell. One of the class II polypeptides (90,000 daltons) is the product of gene C2, which is an essential gene product required for the initiation of class III RNA synthesis. The colicinogenic factor, ColIb, is a plasmid which prevents the normal synthesis of class II and the III bacteriophage T5-specific RNA in infected colicinogenic (ColIb+) cells. In T5-infected colicinogenic cells, only the T5 class I polypeptide is found associated with the RNA polymerase. Mutants of T5, designated T5h minus, are capable of growth on both noncolicinogenic and ColIb+ hosts. Extracts of T5h minus infected ColIb+ cells were shown to lack a small class I polypeptide (12,000 daltons) as compared to T5-infected cells. The h minus mutation, however, has no effect on the levels of the class I T5 polypeptide of similar molecular weight which is bound to the RNA polymerase. One effect of the h minus mutation is to enhance the quantities of the two class II polypeptides bound to the enzyme.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1092331     DOI: 10.1021/bi00676a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  13 in total

1.  Early events after infection of Escherichia coli by bacteriophage T5. II. Control of the bacteriophage-induced 5'-nucleotidase activity.

Authors:  S M Berget; T J Mozer; H R Warner
Journal:  J Virol       Date:  1976-04       Impact factor: 5.103

2.  Cloning, sequencing, and recombinational analysis with bacteriophage BF23 of the bacteriophage T5 oad gene encoding the receptor-binding protein.

Authors:  V Krauel; K J Heller
Journal:  J Bacteriol       Date:  1991-02       Impact factor: 3.490

3.  Isolation and genetic characterizaion of Escherichia coli K-12 mutations affecting bacteriophage T5 restriction by the ColIb plasmid.

Authors:  R Hull; E E Moody
Journal:  J Bacteriol       Date:  1976-07       Impact factor: 3.490

4.  Role of the T5 gene D15 nuclease in the generation of nicked bacteriophage T5 DNA.

Authors:  R W Moyer; C T Rothe
Journal:  J Virol       Date:  1977-10       Impact factor: 5.103

5.  Regulation of the temporal synthesis of proteins in bacteriophage BF23-infected cells.

Authors:  S Kikuchi; K Yoshinari; H Ishimaru; K Mizobuchi
Journal:  J Virol       Date:  1988-12       Impact factor: 5.103

6.  Are class I (pre-early) proteins of bacteriophage T5 sufficient to induce abortive infection of ColIb+ Escherichia coli?

Authors:  J Glenn; A K Cheung; D H Duckworth
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

7.  Is abortive infection by bacteriophage BF23 of Escherichia coli harboring ColIb plasmids due to cell killing by internally liberated colicin Ib?

Authors:  D J McCorquodale; A R Shaw; E E Moody; R A Hull; A F Morgan
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

8.  Amino acid and sugar transport in Escherichia coli (ColIb) during abortive infection by bacteriophage T5.

Authors:  J Glenn; D H Duckworth
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

9.  Cell-free transcription and translation of isolated restriction fragments localize bacteriophage T5 pre-early genes.

Authors:  P W Blaisdell; H R Warner
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

10.  Transcription regulatory elements in the late region of bacteriophage T5 DNA.

Authors:  F Brunel; V H Thi; M F Pilaete; J Davison
Journal:  Nucleic Acids Res       Date:  1983-11-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.